title: Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation.
authors.forename: Iona
authors.initials: I
authors.lastname: Monteiro
authors.forename: Lucille M
authors.initials: LM
authors.lastname: McLoughlin
authors.forename: Adrian
authors.initials: A
authors.lastname: Fisher
authors.forename: Andrew N
authors.initials: AN
authors.lastname: de la Torre
authors.forename: Baburao
authors.initials: B
authors.lastname: Koneru
mesh_terms: D000017:ABO Blood-Group System; D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology; D001787:Blood Group Incompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017093:Liver Failure / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology*; D008212:Lymphocyte Depletion; D008297:Male; D000069283:Rituximab; D013156:Splenectomy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab